Table 1.
Patient characteristics.
| Female | 23 | 36% |
| Male | 41 | 64% |
| Age (years) | 63.5 | ±9.6 |
| BMI (kg/m2) | 25.8 | ±4.4 |
| Entities | ||
| Colorectal metastases | 27 | 42% |
| Hepatocellular cancer | 3 | 5% |
| Intrahepatic Cholangiocarcinoma | 4 | 6% |
| Klatskin tumor | 26 | 41% |
| Other | 4 | 6% |
| Comorbidities | ||
| Coronary heart disease | 7 | 11% |
| Diabetes mellitus | 16 | 25% |
| Arrhythmia | 8 | 13% |
| Renal insufficiency | 5 | 8% |
| Hypertension | 34 | 53% |
| Chronic obstructive pulmonary disease | 9 | 14% |
| Liver parameters | ||
| LiMAxpreop (μg/kg/h) | 372 | ±138 |
| LiMAxpostop (μg/kg/h) | 104 | ±68 |
| Total liver volume (ml) | 1847 | ±528 |
| Future liver remnant (ml) | 461 | ±215 |
| Functional remnant liver volume (%) | 28 | ±12 |
| ASA | 3 | ±1 |
| MELD | 7 | ±2 |
| Child-Pugh | 5 | ±0 |